TSC2 and brain neoplasm: Because of the deficiency of Tsc2, the activity of the Tsc1/Tsc2 complex is decreased, leading to the overactivation of the mTOR pathway, which is the primary cause of TSC-related symptoms, including tumours of the brain, skin, heart, lungs, and kidney [1,21].